Yiyu Qin

Dr. Yiyu Qin


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2019 in Molecular Carcinogenesis
Verified
Journal Article
Open access
PDF file
YFYang Fu
Yang Fu
YYYuhan Yin
Yuhan Yin
SPSanfei Peng
Sanfei Peng
GYGe Yang
Ge Yang
YYYang Yu
Yang Yu
YQYiyu Qin
Yiyu Qin
Small nucleolar RNA host gene 1 (SNHG1) is critical in the progression of cancers. However, the mechanism by which SNHG1 regulates the progression of colorectal cancer (CRC) remains unclear. Expressions of SNHG1 and miR‐137 in CRC tissues and cell lines were evaluated by quantitative real‐time polymerase chain reaction. A luciferase reporter gene assay was conducted to investigate miR‐137 target. Additionally, RNA pull‐down assay was performed to explore the physical association between miR‐137, SNHG1, and RNA induced silencing complex (RISC). Cell cycling and invasion were examined by flow cytometry (FCM) and transwell assays. The in vivo carcinogenic activity of SNHG1 was examined using murine xenograft models. Expression of RICTOR, serine/threonine kinase 1 (AKT), serum and glucocorticoid‐inducible kinase 1 (SGK1), p70S6K1, and LC3II/LC3I ratio was examined by Western blot analysis. SNHG1 upregulation was observed in CRC tissues and cell lines, which was associated with the lymph node metastasis, advanced TNM stage and poorer prognosis. SNHG1 increased RICTOR level in CRC via sponging miR‐137. In addition, SNHG1 silencing inhibited CRC cell proliferation and migration in vitro and in vivo. SNHG1 regulated RICTOR expression by sponging miR‐137 and promoted tumorgenesis in CRC.

13 February 2017 in Oncotarget
Verified
Journal Article
Open access
YQYiyu Qin
Yiyu Qin
LMLi Meng
Li Meng
YFYang Fu
Yang Fu
ZQZhiwei Quan
Zhiwei Quan
MMMingzhe Ma
Mingzhe Ma
KHKoulan Han
Koulan Han
SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling

16 August 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
YQYiyu Qin
Yiyu Qin
YZYongliang Zheng
Yongliang Zheng
CHCheng Huang
Cheng Huang
YLYuanyuan Li
Yuanyuan Li
MGMin Gu
Min Gu
QWQin Wu
Qin Wu
Background: Gallbladder cancer (GBC) is a malignant cancer with poor prognosis. Evidences have shown that miRNAs are closely related to the occurrence of GBC; thus, we aimed to explore miRNAs, which plays an important role in the occurrence and development of GBC. Methods: Microarray analysis was performed to investigate the differentially expressed miRNAs between five non-neoplastic gallbladder tissues (normal tissues) and five gallbladder tumor tissues (tumor tissues). RT-qPCR was performed to detect the level of miR-181b-5p in cells, and CCK-8 was performed to detect cell viability. Then, glucose assay kit or lactic acid assay kit was performed to detect the level of glucose consumption or lactate production. Next, transwell and wound healing assays were used to assess cell migration. In addition, dual-luciferase reporter assay was used to verify the relationship between miR-181b-5p and PDHX. At last, Western blotting was performed to determine the protein level of PDHX. Results: Microarray analysis suggested miR-181b-5p was significantly upregulated in GBC tumor tissue. KEGG analysis for the protein targets of miR-181b-5p indicates a close relationship existed between miR-181b-5p and glycolysis. In addition, the level of miR-181b-5p was notably increased in GBC-SD or G415 cells, compared with HIBEpiC cells. GBC cell viability was significantly decreased under hypoxia, and these decreases were exacerbated by miR-181b-5p antagomir. Moreover, glucose consumption or lactate production of GBC cells was significantly upregulated under hypoxia, whereas these increases were completely revered by miR-181b-5p antagomir. Further investigation revealed that PDHX was a direct target of miR-181b-5p. Conclusion: In this study, downregulation of miR-181b-5p inhibits the viability, migration, and glycolysis of GBC by upregulating PDHX under hypoxia. This finding suggested that miR-181b-5p might be considered as a novel therapeutic target for the treatment of GBC.

1 October 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YQYiyu Qin
Yiyu Qin
YZYang Zhou
Yang Zhou
AGAnxing Ge
Anxing Ge
LCLi Chang
Li Chang
HSHaiyan Shi
Haiyan Shi
QLQiong Luo
Qiong Luo
Gallbladder cancer (GBC) ranks fifth in the most common malignancy of the gastrointestinal tract worldwide. It is reported many small nucleolar RNAs (SNORNs) could regulate the progression of GBC. To identify potential therapeutic targets for GBC, we conducted microarray analysis in GBC tissues and adjacent normal tissues. We found that SNORA21 was downregulated most in gallbladder tumor samples. Therefore, this research aimed to investigate the role of SNORA21 during the tumorigenesis of GBC. The differential expression of SNORNs between GBC tissues and para-carcinoma tissues were examined by microarray analysis and that were confirmed by qRT-PCR. Cell proliferation was tested by CCK-8 and immunofluorescence. Cell apoptosis and cell cycle in GBC were detected by flow cytometry. Expression of proteins in GBC cells was measured by Western-blot. Transwell assay was used for testing the cell migration and invasion. Xenograft tumor model was established to verify the effect of SNORA21 overexpression on GBC in vivo. The results revealed that SNORA21 overexpression inhibited the proliferation, migration and invasion of GBC cells. Moreover, overexpression of SNORA21 significantly increased the expression of E-cadherin and decreased the levels of N-cadherin and vimentin. Meanwhile, overexpression of SNORA21 significantly induced apoptosis and G1 arrest of GBC cells. Finally, SNORA21 overexpression significantly suppressed the growth of gallbladder tumors in vivo. Overexpression of SNORA21 significantly suppressed the tumorigenesis of GBC in vitro and in vivo, which may serve as a potential novel target for the treatment of GBC.

22 September 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
XZXin Zhou
Xin Zhou
SLShaojie Li
Shaojie Li
TMTiexiang Ma
Tiexiang Ma
JZJian Zeng
Jian Zeng
HLHuanyu Li
Huanyu Li
YQYiyu Qin
Yiyu Qin
Colorectal cancer (CRC) is a malignant tumor of the gastrointestinal tract and a leading cause of cancer‑associated mortality worldwide. Mex‑3 RNA binding family member A (MEX3A) promotes the progression of multiple types of cancer, including ovarian and cervical cancer. However, to the best of our knowledge, the role of MEX3A in CRC is not completely understood. Therefore, the present study aimed to investigate the function of MEX3A in CRC. The mRNA and protein expression levels of MEX3A in CRC cells were analyzed using reverse transcription‑quantitative PCR and western blotting, respectively. Cell Counting Kit‑8 assays were used to measure cell viability. Cell apoptosis and cell cycle distribution were detected via flow cytometry, and CRC cell invasion was analyzed by performing Transwell assays. Moreover, the mitochondrial membrane potential in CRC cells was measured via JC‑1 staining. The results of the present study revealed that the expression levels of MEX3A were upregulated in CRC tissues compared with adjacent healthy tissues. MEX3A knockdown notably inhibited CRC cell viability, and induced apoptosis and mitochondrial injury. In addition, MEX3A knockdown markedly induced G1 phase cell cycle arrest in CRC cells via downregulating CDK2 expression. In conclusion, the findings of the present study suggested that MEX3A knockdown may inhibit the tumorigenesis of CRC cells by regulating CDK2 expression. Therefore, MEX3A may serve as a novel target for CRC treatment.

13 October 2016 in Oncology Letters
Verified
Journal Article
Closed access
PDF file
RGRunsheng Guo
Runsheng Guo
YQYiyu Qin
Yiyu Qin
PSPeidong Shi
Peidong Shi
JXJinbi Xie
Jinbi Xie
MCMing Chou
Ming Chou
YCYueyu Chen
Yueyu Chen
Increasing evidence has revealed a correlation between chronic inflammation and gallbladder cancer (GBC). However, the underlying molecular mechanisms remain to be elucidated. In the present study, secretion of interleukin (IL)‑1β was examined in tissues of GBC, chronic cholecystitis and normal gallbladder, as well as in the supernatant of GBC‑SD, SGC996 and HIBEpiC cells. The effect of IL‑1β on the proliferation and migration of GBC cell lines was also evaluated. In addition, the role of Twist in IL‑1β‑induced proliferation of GBC cells was also studied. It was observed that the level of IL‑1β protein in normal gallbladder tissue was low, while it was significantly increased in GBC and chronic cholecystitis tissues. The level of IL‑1β protein and mRNA in GBC‑SD and SGC996 cells was markedly higher than those in HIBEpiC cells. Exogenous IL‑1β promoted the proliferation of GBC‑SD and SGC996 cells in vitro and in vivo, and also promoted migration in vitro. The level of Twist protein was significantly increased following treatment with exogenous IL‑1β. In addition, gene silencing of Twist blocked IL‑1β‑induced proliferation and migration of GBC‑SD and SGC996 cells. Taken together, these results indicate that IL‑1β promotes proliferation and migration of GBC cells via Twist activation.